_scan_pd.jpg)
For the third quarter of 2022 earnings season H Cyte Inc Deficit has widen of $-8.04 per share compare to $0.00 a year before and earnings per share improved from $-11.97 per share from the prior reporting period.
Revenues remained unaltered to $
0.00 millions from $0.46 millions in the comparable reporting period a year before and sequentially from $0.07 millions.
For the third quarter of 2022 earnings season H Cyte Inc realized net loss of $-2.279 million, higher than $-0.587 million a year ago.
H Cyte Inc is expected to report next financial results on February 24, 2023.